Christophe Douat, CEO of Medincell, said: “The initiation of coverage by Truist Securities is a strong endorsement of Medincell’s potential. It confirms the growing interest in our company ...

On Wednesday, Truist Securities initiated coverage on Medincell SA (EPA:MEDCL:FP), assigning a Buy rating and setting a price target of EUR22.00. The new rating underscores the firm’s positive outlook ...

ATLANTA, March 25, 2025 /PRNewswire/ -- Truist Securities announced today that Danielle Brill has joined the firm as managing director, strengthening its equity research coverage in the ...

Christophe Douat, CEO of Medincell, said: "The initiation of coverage by Truist Securities is a strong endorsement of Medincell’s potential. It confirms the growing interest in our company ...

On Wednesday, Truist Securities initiated coverage on Medincell SA (EPA:MEDCL:FP), assigning a Buy rating and setting a price target of EUR22.00. The new rating underscores the firm’s positive ...

Truist Securities, a leading U.S. investment bank with deep expertise in healthcare, has initiated coverage of Medincell The Truist Securities equity research team has issued a “Buy” rating on ...

Truist Securities's initiation of coverage comes as Medincell's first approved and marketed product in the United States, UZEDY a 1-month and 2-month subcutaneous risperidone for schizophrenia ...